cqp 201-403 has been researched along with quinagolide in 2 studies
| Studies (cqp 201-403) | Trials (cqp 201-403) | Recent Studies (post-2010) (cqp 201-403) | Studies (quinagolide) | Trials (quinagolide) | Recent Studies (post-2010) (quinagolide) |
|---|---|---|---|---|---|
| 12 | 4 | 0 | 192 | 43 | 35 |
| Protein | Taxonomy | cqp 201-403 (IC50) | quinagolide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.1333 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 4.1333 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.1086 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.1333 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 4.1333 | |
| D | Bos taurus (cattle) | 0.1086 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 4.6 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.1333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JR; Sheppard, MC; Vidal, ME; Wilson, EM | 1 |
| Adams, EF; Brownell, J; Burrin, JM; Venetikou, MS; Woods, CA; Yeo, TH | 1 |
2 other study(ies) available for cqp 201-403 and quinagolide
| Article | Year |
|---|---|
Suppression of prolactin release and mRNA accumulation by two novel dopamine agonist agents.
Topics: Aminoquinolines; Animals; Cells, Cultured; Cytoplasm; Dopamine Agents; Ergolines; Growth Hormone; Male; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; RNA, Messenger | 1989 |
Effects of two novel dopaminergic drugs, CV 205-502 and CQP 201-403, on prolactin and growth hormone secretion by human pituitary tumours in vitro.
Topics: Aminoquinolines; Animals; Ergolines; Growth Hormone; Humans; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Receptors, Dopamine; Tumor Cells, Cultured | 1987 |